Cerebral Hemorrhages: From Pathophysiologic Mechanisms to Therapeutic Strategies

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 1779

Special Issue Editor


E-Mail Website
Guest Editor
Department of Neurosurgery, Medical School, University of Michigan, Ann Arbor, MI 48109, USA
Interests: Intracerebral hemorrhage; intraventricular hemorrhage; hydrocephalus; traumatic brain injury

Special Issue Information

Dear Colleagues,

Cerebral hemorrhages are a group of diseases (intracerebral hemorrhage, intraventricular hemorrhage, subarachnoid hemorrhage, etc.) that induce brain damage and subsequent functional impairment. Brain edema, vasospasm, breakdown of the blood‒brain barrier, activation of microglia/macrophages, and remodeling of the perilesional environment are major pathological substrates in hemorrhagic stroke. A wide variety of conditions, risk factors, and disorders (such as hypertension, aneurysm, tumor, trauma, arteriovenous malformation, moyamoya disease, etc.) lead to cerebral hemorrhages, although the underlying pathophysiologic mechanisms remain unclear and effective treatments are limited.

This Special Issue, titled “Cerebral hemorrhages: From Pathophysiologic Mechanisms to Therapeutic Strategies”, focuses on the pathophysiologic mechanisms of primary and secondary brain injury, the mechanism of aging and sex differences, mechanisms of impaired blood‒cerebrospinal fluid barriers, and perilesional environment remodeling leading to immune cells infiltration and microbleeds. This Special Issue also welcomes articles that provide an overview of the role of white matter injury, phagocytosis, hemolysis, and immune system molecular mechanisms in the pathogenesis of cerebral hemorrhage diseases and corresponding treatment approaches. As such, this Special Issue welcomes submissions of original research and review articles related to any aspect of the pathophysiologic mechanisms and therapeutic strategies of hemorrhagic stroke diseases.

Dr. Yingfeng Wan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hemorrhagic stroke
  • white matter injury
  • brain blood barrier
  • phagocytosis
  • hemolysis
  • immune cells
  • aging
  • sex difference
  • vasospasm
  • blood‒cerebrospinal fluid barrier

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

12 pages, 1695 KiB  
Article
Identifying Predictors of Initial Surgical Failure during Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
by Turner S. Baker, Roshini Kalagara, Ayesha Hashmi, Benjamin Rodriguez, Shelley H. Liu, Hana Mobasseri, Colton Smith, Benjamin Rapoport, Anthony Costa and Christopher P. Kellner
Biomedicines 2024, 12(3), 508; https://doi.org/10.3390/biomedicines12030508 - 23 Feb 2024
Viewed by 630
Abstract
Background and Purpose: Intracerebral hemorrhage (ICH) is a common and severe disease with high rates of morbidity and mortality; however, minimally invasive surgical (MIS) hematoma evacuation represents a promising avenue for treatment. In February of 2019, the MISTIE III study found that [...] Read more.
Background and Purpose: Intracerebral hemorrhage (ICH) is a common and severe disease with high rates of morbidity and mortality; however, minimally invasive surgical (MIS) hematoma evacuation represents a promising avenue for treatment. In February of 2019, the MISTIE III study found that stereotactic thrombolysis with catheter drainage did not benefit patients with supratentorial spontaneous ICH but that a clinical benefit may be present when no more than 15 mL of hematoma remains at the end of treatment. Intraoperative CT (iCT) imaging has the ability to assess whether or not this surgical goal has been met in real time, allowing for operations to add additional CT-informed ‘evacuation periods’ (EPs) to achieve the surgical goal. Here, we report on the frequency and predictors of initial surgical failure on at least one iCT requiring additional EPs in a large cohort of patients undergoing endoscopic minimally invasive ICH evacuation with the SCUBA technique. Methods: All patients who underwent minimally invasive endoscopic evacuation of supratentorial spontaneous ICH in a major health system between December 2015 and October 2018 were included in this study. Patient demographics, clinical and radiographic features, procedural details, and outcomes were analyzed retrospectively from a prospectively collected database. Procedures were characterized as initially successful when the first iCT demonstrated that surgical success had been achieved and initially unsuccessful when the surgical goal was not achieved, and additional EPs were performed. The surgical goal was prospectively identified in December of 2015 as leaving no more than 20% of the preoperative hematoma volume at the end of the procedure. Descriptive statistics and regression analyses were performed to identify predictors of initial failure and secondary rescue. Results: Patients (100) underwent minimally invasive endoscopic ICH evacuation in the angiography suite during the study time period. In 14 cases, the surgical goal was not met on the first iCT and multiple Eps were performed; in 10 cases the surgical goal was not met, and no additional EPs were performed. In 14 cases, the surgical goal was never achieved. When additional EPs were performed, a rescue rate of 71.4% (10/14) was seen, bringing the total percentage of cases meeting the surgical goal to 86% across the entire cohort. Cases in which the surgical goal was not achieved were significantly associated with older patients (68 years vs. 60 years; p = 0.0197) and higher rates of intraventricular hemorrhage (34.2% vs. 70.8%; p = 0.0021). Cases in which the surgical goal was rescued from initial failure had similar levels of IVH, suggesting that these additional complexities can be overcome with the use of additional iCT-informed EPs. Conclusions: Initial and ultimate surgical failure occurs in a small percentage of patients undergoing minimally invasive endoscopic ICH evacuation. The use of intraoperative imaging provides an opportunity to evaluate whether or not the surgical goal has been achieved, and to continue the procedure if the surgeon feels that more evacuation is achievable. Now that level-one evidence exists to target a surgical evacuation goal during minimally invasive ICH evacuation, intraoperative imaging, such as iCT, plays an important role in aiding the surgical team to achieve the surgical goal. Full article
Show Figures

Figure 1

Review

Jump to: Research

12 pages, 2133 KiB  
Review
The Hemorrhagic Side of Primary Angiitis of the Central Nervous System (PACNS)
by Marialuisa Zedde, Manuela Napoli, Claudio Moratti, Francesca Romana Pezzella, David Julian Seiffge, Georgios Tsivgoulis, Luigi Caputi, Carlo Salvarani, Danilo Toni, Franco Valzania and Rosario Pascarella
Biomedicines 2024, 12(2), 459; https://doi.org/10.3390/biomedicines12020459 - 19 Feb 2024
Viewed by 716
Abstract
Primary Angiitis of the Central Nervous System (PACNS) is a rare cerebrovascular disease involving the arteries of the leptomeninges, brain and spinal cord. Its diagnosis can be challenging, and the current diagnostic criteria show several limitations. Among the clinical and neuroimaging manifestations of [...] Read more.
Primary Angiitis of the Central Nervous System (PACNS) is a rare cerebrovascular disease involving the arteries of the leptomeninges, brain and spinal cord. Its diagnosis can be challenging, and the current diagnostic criteria show several limitations. Among the clinical and neuroimaging manifestations of PACNS, intracranial bleeding, particularly intracerebral hemorrhage (ICH), is poorly described in the available literature, and it is considered infrequent. This review aims to summarize the available data addressing this issue with a dedicated focus on the clinical, neuroradiological and neuropathological perspectives. Moreover, the limitations of the actual data and the unanswered questions about hemorrhagic PACNS are addressed from a double point of view (PACNS subtyping and ICH etiology). Fewer than 20% of patients diagnosed as PACNS had an ICH during the course of the disease, and in cases where ICH was reported, it usually did not occur at presentation. As trigger factors, both sympathomimetic drugs and illicit drugs have been proposed, under the hypothesis of an inflammatory response due to vasoconstriction in the distal cerebral arteries. Most neuroradiological descriptions documented a lobar location, and both the large-vessel PACNS (LV-PACNS) and small-vessel PACNS (SV-PACNS) subtypes might be the underlying associated phenotypes. Surprisingly, amyloid beta deposition was not associated with ICH when histopathology was available. Moreover, PACNS is not explicitly included in the etiological classification of spontaneous ICH. This issue has received little attention in the past, and it could be addressed in future prospective studies. Full article
Show Figures

Figure 1

Back to TopTop